Erythromycin eye ointment: effect on gastrointestinal motility.
Moussa
F
F
Alaswad
B
B
Garcia
J
J
D000287:Administration, Topical; D003228:Conjunctiva / Q000187:drug effects; D004917:Erythromycin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009824:Ointments; D011964:Receptors, Gastrointestinal Hormone / Q000819:agonists; D018013:Receptors, Neuropeptide / Q000819:agonists; D012189:Retrospective Studies; D012835:Silver Nitrate / Q000008:administration & dosage / Q000009:adverse effects; D014141:Trachoma / Q000517:prevention & control*
D009824:Ointments; D011964:Receptors, Gastrointestinal Hormone; D018013:Receptors, Neuropeptide; C050802:motilin receptor; D004917:Erythromycin; D012835:Silver Nitrate